Matches in Wikidata for { <http://www.wikidata.org/entity/Q65382250> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q65382250 description "clinical trial" @default.
- Q65382250 description "ensayu clínicu" @default.
- Q65382250 description "klinisch onderzoek" @default.
- Q65382250 description "клінічне випробування" @default.
- Q65382250 name "Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)" @default.
- Q65382250 name "Study of Extended Release Niacin/Laropiprant on Lipids" @default.
- Q65382250 type Item @default.
- Q65382250 label "Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)" @default.
- Q65382250 label "Study of Extended Release Niacin/Laropiprant on Lipids" @default.
- Q65382250 prefLabel "Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)" @default.
- Q65382250 prefLabel "Study of Extended Release Niacin/Laropiprant on Lipids" @default.
- Q65382250 P1132 Q65382250-09F5C531-F0EF-4C76-BCF4-A7FA90E4286A @default.
- Q65382250 P1476 Q65382250-5E9540DE-09D1-42FF-A385-9CF8F9D1384E @default.
- Q65382250 P2899 Q65382250-0A057D66-4B01-4838-BF5D-A08D15C79C93 @default.
- Q65382250 P3098 Q65382250-82FBF7B4-3F33-46E8-AA00-4BAE0B7E21F5 @default.
- Q65382250 P31 Q65382250-C092B981-2521-468E-AAF7-CC9C404BDFC6 @default.
- Q65382250 P4135 Q65382250-EBE46D84-0979-4796-860B-4C56AF891CCB @default.
- Q65382250 P4844 Q65382250-46664B2A-D2A9-44C4-9AC8-BB3AA2AD4925 @default.
- Q65382250 P4844 Q65382250-68CA45CD-4F81-4BDF-AA03-FD663FD013A5 @default.
- Q65382250 P4844 Q65382250-6EEE294A-1167-47C7-A5BD-917672C442F4 @default.
- Q65382250 P580 Q65382250-ECF3050A-6B5F-44F7-AED1-F8415FEE7A41 @default.
- Q65382250 P582 Q65382250-8038E459-F9B0-4D06-8F82-8988D46C3454 @default.
- Q65382250 P6099 Q65382250-18F4F45A-37BA-4FAC-A4BC-4475974ABB47 @default.
- Q65382250 P8363 Q65382250-D474F0E8-C2E7-4A3A-8E15-CE0B1DE2ECF6 @default.
- Q65382250 P1132 "+1216" @default.
- Q65382250 P1476 "A Multicenter, Randomized, Double-Blind, Parallel Group, 12 Week Study to Evaluate the Efficacy and Safety of Extended-release (ER) Niacin/Laropiprant in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia." @default.
- Q65382250 P2899 "+18" @default.
- Q65382250 P3098 "NCT00479388" @default.
- Q65382250 P31 Q30612 @default.
- Q65382250 P4135 "+80" @default.
- Q65382250 P4844 Q134658 @default.
- Q65382250 P4844 Q192423 @default.
- Q65382250 P4844 Q412399 @default.
- Q65382250 P580 "2007-07-01T00:00:00Z" @default.
- Q65382250 P582 "2008-07-01T00:00:00Z" @default.
- Q65382250 P6099 Q42824827 @default.
- Q65382250 P8363 Q78089383 @default.